PEN 239.2 (+0.88%)
US70975L1070Medical Devices & InstrumentsMedical Devices

Penumbra (PEN) Financial Metrics

This table shows a selected set of financial data points of Penumbra (PEN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 2.37 0 106.2 9.66B 0.06 1.06B 82.12M 126.86M 90.95M 167.49M
2022 -0.05 0 -4.21K 8.42B -0 847.13M -74.96M 29.96M -2M 69.86M
2021 0.14 0 2K 10.56B 0.01 747.59M -11.68M 7.84M 5.28M 59.38M
2020 -0.44 0 -398.63 6.26B -0.02 560.41M -58M -26.05M -15.7M 69.67M
2019 1.39 0 117.81 5.71B 0.08 547.41M 4.54M 47.51M 48.46M 72.78M
2018 0.18 0 668.12 4.41B 0.01 444.94M 19.21M 8.37M 6.6M 67.85M
2017 0.13 0 713.42 3.32B 0.01 333.76M -2.34M 4.83M 4.66M 50.64M
2016 0.44 0 144.18 2.14B 0.05 263.32M -26.44M 1.43M 14.81M 13.24M
2015 0.17 0 323.57 765.16M 0.01 186.1M -27.75M 5.78M 2.37M 19.55M
2014 0.09 0 0 0 0.02 125.51M -10.28M 3.89M 2.25M 3.29M
2013 0.17 0 0 0 0.12 88.85M -4.19M -578K 4.1M 4.13M
2012 0.08 0 0 0 0 73.14M 0 3.89M 1.96M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.